US 11787839
Targeting α2δ-1-bound glutamate receptors for treating diseases and disorders
granted A61KA61K31/485A61K31/515
Quick answer
US patent 11787839 (Targeting α2δ-1-bound glutamate receptors for treating diseases and disorders) held by The Board of Regents of the University of Texas System expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/485, A61K31/515, A61K31/5513, A61K38/00